Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Cost effectiveness of the type II Boston keratoprosthesis.

Ament JD, Stryjewski TP, Pujari S, Siddique S, Papaliodis GN, Chodosh J, Dohlman CH.

Eye (Lond). 2011 Mar;25(3):342-9. doi: 10.1038/eye.2010.197. Epub 2010 Dec 24.

2.

Keratoprosthesis surgery.

Liu C, Hille K, Tan D, Hicks C, Herold J.

Dev Ophthalmol. 2008;41:171-86. doi: 10.1159/000131088. Review.

PMID:
18453768
3.

A review of corneal melting after Boston Keratoprosthesis.

Robert MC, Dohlman CH.

Semin Ophthalmol. 2014 Sep-Nov;29(5-6):349-57. doi: 10.3109/08820538.2014.959186. Review.

PMID:
25325860
4.

Keratoprosthesis: an update.

Khan B, Dudenhoefer EJ, Dohlman CH.

Curr Opin Ophthalmol. 2001 Aug;12(4):282-7. Review.

PMID:
11507341
5.

The osteo-odonto-keratoprosthesis (OOKP).

Liu C, Paul B, Tandon R, Lee E, Fong K, Mavrikakis I, Herold J, Thorp S, Brittain P, Francis I, Ferrett C, Hull C, Lloyd A, Green D, Franklin V, Tighe B, Fukuda M, Hamada S.

Semin Ophthalmol. 2005 Apr-Jun;20(2):113-28. Review.

PMID:
16020351
6.

Keratoprostheses in clinical practice - a review.

Gomaa A, Comyn O, Liu C.

Clin Exp Ophthalmol. 2010 Mar;38(2):211-24. doi: 10.1111/j.1442-9071.2010.02231.x. Review.

PMID:
20398109
7.

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ.

Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Review.

8.

[Clinical management of severe ocular surface disease].

Stoiber J, Grabner G.

Klin Monbl Augenheilkd. 2005 Jul;222(7):533-51. Review. German.

PMID:
16034721
9.

Expanding indications for the Boston keratoprosthesis.

Colby KA, Koo EB.

Curr Opin Ophthalmol. 2011 Jul;22(4):267-73. doi: 10.1097/ICU.0b013e3283477d0d. Review.

PMID:
21537184
10.

Review of endophthalmitis following Boston keratoprosthesis type 1.

Robert MC, Moussally K, Harissi-Dagher M.

Br J Ophthalmol. 2012 Jun;96(6):776-80. doi: 10.1136/bjophthalmol-2011-301263. Epub 2012 Apr 4. Review.

PMID:
22493035
11.
12.

Keratoprosthesis in autoimmune disease.

Ciralsky J, Papaliodis GN, Foster CS, Dohlman CH, Chodosh J.

Ocul Immunol Inflamm. 2010 Aug;18(4):275-80. doi: 10.3109/09273941003682300. Review.

PMID:
20662659
13.

[Current treatment options with artificial corneas: Boston Kpro, Osteo-odontokeratoprosthesis, Miro Cornea® and KeraKlear®].

Schrage N, Hille K, Cursiefen C.

Ophthalmologe. 2014 Nov;111(11):1010-8. doi: 10.1007/s00347-013-3009-5. Review. German.

PMID:
25388085
14.

Keratoprostheses for corneal blindness: a review of contemporary devices.

Avadhanam VS, Smith HE, Liu C.

Clin Ophthalmol. 2015 Apr 16;9:697-720. doi: 10.2147/OPTH.S27083. eCollection 2015. Review.

15.

Low-cost and readily available tissue carriers for the Boston keratoprosthesis: a review of possibilities.

Cruzat A, Tauber A, Shukla A, Paschalis EI, Pineda R, Dohlman CH.

J Ophthalmol. 2013;2013:686587. doi: 10.1155/2013/686587. Epub 2013 Nov 24. Review.

16.
17.

Boston type 1 keratoprosthesis from patient selection through postoperative management: a review for the keratoprosthetic surgeon.

Williamson SL, Cortina MS.

Clin Ophthalmol. 2016 Mar 14;10:437-43. doi: 10.2147/OPTH.S83677. eCollection 2016. Review.

Supplemental Content

Support Center